G&E Herbal Biotechnology Co Ltd

Capital Structure and Liquidity G&E Herbal Biotechnology has a market price of TWD 34.3 and a market capitalization of TWD 2,185,596,000. The company has no disclosed diluted shares beyond the basic 63,720,000 shares outstanding, indicating no immediate dilution pressure from stock options or convertible instruments. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. ### Profitability and Returns No profitability metrics or returns data are available in the provided valuation snapshot, making it impossible to compare the company's performance against industry_config preferred metrics or cohort medians. This lack of data limits the ability to assess the company's financial health relative to its peers. ### Segments and Geographic Exposure The company operates in three primary segments: healthcare food products, functional skincare products, and pharmaceuticals. It distributes its products domestically in Taiwan and to overseas markets, though the exact geographic revenue breakdown is not disclosed. The absence of detailed segment and geographic revenue data limits the ability to assess exposure to specific regions or product lines. ### Growth Trajectory No growth trajectory data is available in the provided outlook, including current or next fiscal year direction or numeric deltas. The lack of revenue history and forward-looking guidance prevents an assessment of the company's growth potential. ### Risk Factors and Dilution The company faces a key risk of unassessable liquidity due to missing balance-sheet inputs and no going-concern language in source documents. Dilution risk is currently low, as there is no evidence of dilutive instruments or recent equity issuance. No adjustments have been applied to the valuation due to the lack of relevant data. ### Recent Events No recent events, such as filings or transcripts, are provided in the input data to inform the company's current strategic or operational developments.